17 May 2017 | News
Azilsartan, a new generation Anti-hypertensive drug, offers potent and persistent 24 hours’ blood pressure control
With an aim of reducing hypertension, Mankind Pharma recently launched Anti-Hypertensive-drug Zolahart (Azilsartan), at an affordable price of Rs 7.50 per tablet.
Research by the World Health Organization (WHO), shows that hypertension is one of the leading causes of premature deaths in India. It also exerts substantial public health burden on the cardiovascular health status of India.
Azilsartan is a new generation Anti-hypertensive drug that offers potent and persistent 24 hours’ blood pressure control. It is proven to be safe for hypertensive patients with comorbid conditions like Diabetes or Chronic Kidney Disease (CKD). The recently launched Angiotensin-receptor-blocker (Azilsartan) is the most potent amongst ARBs and is expected to reduce the proportion of patients of uncontrolled BP considerably.
Speaking on the development, Mr. R.C. Juneja, chairman and founder, Mankind Group said “At Mankind, we endeavour to bring the latest innovative therapies with assured quality that address primary healthcare challenge in India – world class quality at an affordable price. It is with this thought, we decided to launch Zolahart (Azilsartan), the latest Anti-Hypertensive Drug at the most affordable price of 7.50/Tab” which is 51% less than other competitors.